Toxicology and the practice of pathology are rapidly evolving in the postgenomic era. Observable treatment related changes have been the hallmark of toxicology studies. Toxicogenomics is a powerful new tool that may show gene and protein changes earlier and at treatment levels below the limits of detection of traditional measures of toxicity. It may also aid in the understanding of toxic mechanisms. It is important to remember that it is only a tool and will provide meaningful results only when properly applied. As is often the case with new experimental tools, the initial utilization is driven more by the technology than application to problem solving. Toxicogenomics is interdisciplinary in nature including at a minimum, pathology, toxicology, and genomics. Most studies will require the input from the disciplines of toxicology, pathology, molecular biology, bioinformatics, biochemistry, and others depending on the types of questions being asked.
INTRODUCTION
The field of toxicology is concerned with characterizing the response of an organism to toxic insult and determining, to the extent possible, the mechanisms involved in the response (Afshari et al., 1999) . Traditionally "toxic" has been defined by an observable, treatment related adverse event. The adverse event might include grossly observable alterations in body weight or organ weights, or histological changes such as hepatocellular necrosis, or changes in clinical chemical or hematological parameters, or more commonly, a combination of all of the above. These types of measurements, along with a number of biochemical assays intended to monitor the activities of various classes of enzymes e.g. cytochrome P450's, as well as toxicokinetics, have represented the major tools available to the practicing toxicologist. The development of toxicogenomics now promises to put a particularly powerful tool at the disposal of toxicologists (Blanchard et al., 2000; Cunningham et al., 2000; Pennie et al., 2000; Bartosiewicz et al., 2001) . Moreover, this tool has the potential to uncover adverse events at treatment levels below the limits of detection of traditional measures of toxicity, at much earlier times, and provide a wealth of mechanistic information. Although toxicogenomics includes genomics, metabonomics and proteomics, the major emphasis in this paper will be on the genomic component, and in particular transcriptional profiling using microarrays.
Conducting toxicogenomic studies requires the input of a diverse spectrum of experts including geneticists, molec-ular biologists, bioinformaticists, engineers, toxicologists, pathologists, and others. Toxicogenomics is a data-rich endeavor and even a small study can generate 200,000 or more data points (Afshari et al., 1999; Blanchard et al., 2000) . The data is also diverse and may include ultrastructural evaluations, histopathology diagnoses, clinical chemistry, and biochemistry in addition to evaluation of mRNA levels for thousands of genes. The amount and complexity of the data means that confounding factors can easily be missed and potential important changes may be overlooked (Churchill, 2002) . Thus each expert needs to be involved in study design and communicate the results, as well as the strengths and potential weaknesses of their data, to the toxicogenomic team.
As an important new tool for high-throughput measurements of gene expression, considerable thought has been given to sources of error in the technical conduct of microarray measurements and analysis of microarray data (Kerr et al., 2000; Brown et al., 2001; Brody et al., 2002) . Much less thought has been given to the sources of variability that may result from toxicological, pathological, and biological components of the animals under study (Boorman et al., 2002b) . Pathologists and toxicologists have a background in chemistry and toxicokinetics, circadian effects, the influence of route and dose, biology of the test species, regional differences in tissues, and animal husbandry, all of which are potential sources of variability for the study (Boorman et al., 2002a) .
Some of this variability can be explained at the microscopic level. Histopathology and electron microscopy can identify cellular infiltrates and regional variations in toxic response within the whole tissue that will impact gene expression and provide the phenotypic anchor for gene changes suggestive of damage to cellular organelles. Pathologists and toxicologists, by understanding the biology of the whole animal, the in vivo Vol. 32(Suppl. 1), 2004 TOXICOGENOMICS BASICS FOR TOXICOLOGY 73 tissue changes and the interaction of toxicities in one organ on the function of other organs, can help put gene expression changes in context. Furthermore greater knowledge of the microarray procedures and the mathematical concepts underlying data analysis will allow pathologists and toxicologists to become more effective team members. Transcriptional profiling is not a new technique and its origins are rooted in the discovery that single stranded DNA could be trapped on nitrocellulose membranes (a solid support) and remain intact. This provided a rapid and specific method for screening RNA populations and led to the development of various hybridization-based blotting methods and ultimately to dot-blots, the precursors of microarrays. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) represents one of the more accurate methods of transcriptional profiling (Bustin, 2000) . Its major restriction as a screening tool is that, with present technology, the number of samples that can be analyzed simultaneously is limited. Microarrays provide a tool for simultaneously measuring the relative level of 20,000 to 25,000 transcripts from a single (small) sample of RNA. It is this ability to provide global information about the expression status of a significant portion of the genome that distinguishes microarrays from other forms of transcriptional profiling. At the same time, analyzing the sheer volume of data provided by microarrays into useful information poses the greatest difficulty in their application (Kaminski, 2000; Churchill, 2002) .
MICROARRAY BASICS
Processing and Transformation of Two Color Microarray Data: Simply stated microarray technology allows for the simultaneous monitoring of relative expression levels for thousands of genes between two populations of mRNA (i.e., between tissues from treated and control animals, diseased or normal animals, or between tissue mRNA and a standard mRNA pool). For example, in a typical 2 color microarray experiment, a sample from a treatment group is labeled with cy5, a dye that fluoresces red, and a sample from the control group is labeled with cy3, a dye that fluoresces green; the labeled samples are mixed and competitively hybridized to a microarray. Depending on the platform, each element on the microarray can be either an oligonucleotide or cDNA representing a single gene (Afshari et al., 1999) . The sample of RNA from the treatment group will contain transcripts whose abundance has been altered (increased or decreased) by the treatment. If the abundance of a particular transcript has been increased relative to control, then more "red" transcripts than "green" transcripts will be hybridized to the element (gene) on the microarray. If the transcript abundance is reduced by treatment, just the reverse will occur and more of the "green" transcripts will be hybridized to the element. If the transcript abundance is unchanged, approximately equal amounts of red and green labeled transcripts will hybridize to the complementary microarray element. When each microarray element is scanned, a fluorescent signal will be measured separately for both red and green fluorescence. The collection of red and green fluorescent signals, 1 pair for each element on the microarray, representing the ratio of treated and control RNA hybridized to that element, is the raw data from the experiment.
Data files containing the raw data are normally evaluated with some type of image analysis software that examines each microarray element, corrects for background fluorescence, and eliminates data with measurement quality problems. Typically the background corrected data is now subject to some standard transformations to make it more suitable for statistical and biological analysis between biological samples (Ishi et al., 2000; Schuchhardt et al., 2000; Kepler et al., 2002) . A common data transformation is normalization. Normalization adjusts for possible differences in detector sensitivity between the red and green channel, differences in the efficiency of the labeling reaction between cy5 and cy3, slight differences in the amount of RNA hybridized to each microarray, as well as other types of systematic bias associated with experimental or biological variability. Another common transformation is to convert the raw data to the logarithm to base 2 (log(2)) of the ratio of treated to control (treated intensity/control intensity) for each array element (Quackenbush, 2002) . The use of logarithms ensures that increases or decreases in gene expression of the same magnitude will be represented as numerically equal but of opposite signs. Often weak signals below a given intensity will also be eliminated.
Nylon cDNA Arrays: Among the earliest microarrays were cDNA's attached to nylon membranes (Apte and Siebert, 1993; Jokhadze et al., 2003) . These arrays are often called Atlas arrays (company name for the arrays) or Clontech arrays for the company that produces them. Atlas arrays utilize radioactive probes that are detected by phosporimagers. This system allows some quantification of the amount of bound probe but the images are not as distinct as those based on fluorescence detection. The major short coming of the Atlas arrays is that they contain fewer elements (usually about 1200), and because they utilize radioactive detection of bound transcripts, genes that are highly over expressed can "bleed" into the adjacent elements on the membrane autoradiography giving false positives (Crosby et al., 2000) . Thus it is important to examine the actual array image in addition to the computergenerated gene lists derived from the array. Atlas arrays have been used in toxicology studies (Crosby et al., 2000; Hester et al., 2003) and cell differentiation (Beck et al., 2001) .
High Density Synthetic Oligonucleotide Arrays: Affymetrix produces a high-density oligonucleotide array consisting of 25-mer oligonucleotides. To ensure specificity each gene on the array is represented by a set of oligonucleotide probe pairs. One member of each pair has a sequence that is a perfect match complement to a sequence in the gene of interest. The other member of the pair contains a single mismatched base directly in the center of the oligonucleotide. (Lockhart et al., 1996; Lipshutz et al., 1999) . Instead of using cy5 and cy3 to distinguish sample from control, the Affymetrix system uses an antisense copy of RNA labeled with biotinylated nucleotides and after hybridization the chip is treated with streptavidin labeled with-phycoerythrin, a fluorescent label, and read with a scanner. For each gene on the array, and for each pair representing that gene, the final hybridization intensities are determined by subtracting the hybridization intensities of the mismatched element from that of the corresponding perfect match to correct for control and nonspecific binding (Bertucci et al., 1999) . Many of the recent studies on altered gene expression in human tumors TOXICOLOGIC PATHOLOGY use the Affymetrix platform (Aldren et al., 2003; Logsdon et al., 2003; Tschentscher et al., 2003) .
All platforms have had some technical problems. Gene annotation, location of the gene on the chip, and even the programs generating gene lists are potential sources of error. Therefore, one must always ask whether the results make biological sense and confirm a subset of genes using quantitative PCR.
Biological and Technical Replicates: Biological replicates refer to numbers of animals per treatment and control group whereas technical replicates refer to the number of measurements made with each sample from an indvidual animal. The importance of biological replicates cannot be overemphasized. Gene expression data is sufficiently sensitive to document the small gene changes in individual animals. Therefore biological replicates are necessary to allow an assessment of variation in the response of individual animals in both the treated and control groups. Of equal importance are technical replicates that allow assessment of experimental variation associated with sample handling. One frequently used technical replicate for 2 color microarrays is a dye reversal, where the control RNA sample is labeled with cy5 (red) and the treated RNA sample is labeled with cy3 (green). This is often called a "flour-flip" and theoretically should provide a value for the log(2) ratio of treated/control signal very similar to that observed with the dye labeling reversed. Any differences are a reflection of bias in the labeling reaction or in the fluorescence yield, or both, although fluor bias does not appear to be a major source of error in two color microarray studies (Yue et al., 2001; Dobbin et al., 2003) . Thus the RNA sample from each animal in the treated and control group is divided into two portions, one of which is labeled with the normal dye orientation and one with the reverse dye orientation. Each of the 2 samples is hybridized to a separate microarray, scanned, corrected for background, normalized, and possibly transformed to log(2) (intensity ratio). The mean value of the background corrected, normalized spot intensities or log intensity ratios are then calculated for each gene on the array. In studies conducted at the National Center for Toxicogenomics (NCT) at NIEHS a minimum of 3 individual treated animals per group are hybridized against three pooled controls and a dye reversal is run for each animal. With 3 animals per group and 2 arrays per animal (normal dye orientation and fluor reversal) this provides 6 arrays per group.
Overview of Gene Expression Profiling and Gene
Discovery: The object of performing transcriptional profiling with microarrays is to identify genes whose expression is altered by treatment with the agent under study. Intuitively, the most obvious candidates would be genes whose expression exhibited the greatest change between treated and control animals. One approach to making this selection is to assume that those genes showing the greatest fold increase or decrease in expression in the treated animals relative to controls are most likely associated with the treatment. For example, a gene might be considered differentially expressed if it is twofold increased or decreased in expression level in treated animals. However, since the selection of a threshold is arbitrary it provides no level of confidence about statistical significance. Further, the reliability of the fold increase or decrease depends on the spot intensity and may be less reliable for genes with low expression levels.
A statistically based approach that is frequently used is to calculate the mean and standard deviation of the distribution of log(2) intensity ratios and then select as differentially expressed, those genes whose expression level falls outside the 95% confidence interval (Quackenbush, 2002) . This is a relatively simple procedure to apply and provides a statistically based method of selection. More recently ANOVA based analyses are being developed that determine the statistical significance of increases or decreases in the expression level of individual genes (Kerr et al., 2000; Park et al., 2003) . This will provide a solid statistical basis, based on p values, for identification of differentially expressed genes. Statistically based selection of differentially expressed genes allows selection not only of genes exhibiting a large fold increase or decrease in expression but also of genes whose change in expression level may be small in magnitude, but can be measured with high precision. It is anticipated that many important genes will fall into this latter category. An important message for the pathologist and toxicologist is that the selection of differentially expressed genes will depend to a great extent on the method used, and statistically based methods provide the most reliable and unbiased way of making that selection. However at the present time microarrays provide only semiquantitative information about changes in gene expression. Therefore it is important to verify with quantitative PCR the expression levels of a representative sample of genes identified on microarrays as being differentially expressed.
Regardless of the method employed, the identification of differentially expressed genes is only a prelude to the real work of making biological sense of the data. Depending on the particular experiment and tissue being studied the list could contain hundreds or possibly more than a thousand genes. The task is to organize this mountain of data into a form that lends itself to meaningful interpretation. In the following sections we will discuss some of the approaches we have found useful for analyzing microarray gene expression data for the liver.
Cluster Analysis: The first step in gaining some understanding of microarray data is to organize it in a meaningful way. For this purpose cluster analysis has proven to be an extremely useful method for analyzing and visualizing microarray data, and in particular, clustering combined with color keyed visualization has been very useful (Eisen et al., 1998) . Cluster analysis is a general term describing a group of statistical methods for ordering data into groups or "clusters" in such a way that members of a particular cluster are more similar to each other in some specified way than they are similar to members of other clusters (Shannon et al., 2003) . Cluster analysis is a statistically based way of organizing and ordering data when there are no a priori hypotheses about how the data should be grouped. The object of performing cluster analysis with gene expression data is to group together genes whose pattern of expression is similar to one another but differs from that of genes in other clusters. In many instances, genes that cluster together and with similar patterns of expression may be involved in similar or related biological functions (Wodicka et al., 1997) . Therefore cluster analysis provides an initial, unsupervised ordering of the gene expression data into groups of genes with similar patterns of expression. Individual genes within each cluster may then be examined to determine their possible relatedness.
Although a number of clustering algorithms are available (Dougherty et al., 2002) , in the work discussed here we have exclusively used Hierarchical clustering as described by Eisen et al . Hierarchical clustering has been used to group genes with similar expression patterns in breast cancer (Perou et al., 2000) , to separate uvula melanomas into 2 groups (Tschentscher et al., 2003) , to discover subtypes of B-cell lymphoma in humans (Alizadeh et al., 2000) and many other uses.
Application of Gene Expression Profiling and Gene Discovery: The liver plays an important role in the toxicology and pharmacology of numerous compounds. Orally administered drugs are transported first to the liver where they may undergo first pass metabolism before being distributed systemically. For several of these compounds hepatotoxicity associated with first pass metabolic transformations is the toxic response that limits the dose that can be safely administered. Technically the liver is easily sampled or removed, and high quality RNA can be readily prepared from liver tissue making it ideal for gene expression profiling. Therefore we have selected a well-known hepatotoxicant, acetaminophen, as an example.
Acetaminophen is among the most highly consumed chemicals in the world (Bessems and Vermeulen, 2001) . In spite of its long history of use, the mechanism thought to underlie its analgesic anti-inflammatory action was only recently discovered (Schwab et al., 2003) . The hepatic metabolism of acetaminophen has been studied extensively and is summarized in Figure 1 . At therapeutic doses the major route of metabolism involves conversion of acetaminophen to a sulfate and glucuronide conjugate, and elimination pri- marily in urine (Bessems and Vermeulen, 2001) . A minor pathway involves the cytochrome P450 catalyzed conversion of acetaminophen to N-acetyl-p-benzo quinone imine (NAPQI), a highly reactive compound that is normally detoxified by conjugate formation with glutathione via glutathiones-transferases (Hazai et al., 2002) . At sufficiently high doses, the rate and capacity for sulfation and glucuronidation begin to be limiting and the amount of parent compound processed by the CYP 450 pathway increases, resulting in the formation of increasing concentrations of NAPQI and requiring greater amounts of glutathione for detoxification.
Glutathione is the major intracellular anti-oxidant in hepatocytes (Mitchell et al., 1973b; Frey et al., 1999) . It plays an especially important role in mitochondria where it is involved in detoxification of reactive oxygen species generated during electron transport. However glutathione is synthesized in the cytosol and must be transported into mitochondria. Depletion of cytosolic glutathione associated with the action of GST's in detoxification of NAPQI results in depletion of mitochondrial glutathione, and increases the risk that reactive oxygen species generated during electron transport will damage the mitochondrial ATP generating mechanism. NAPQI is also an opportunistic alkylator that reacts with protein nucleophiles in the cytoplasm leading to inactivation of the modified proteins (Bessems and Vermeulen, 2001) .
cDNA Microarray Analysis: The cDNA microanalysis has been described in detail (Hamadeh et al., 2002a; Hamadeh et al., 2002b) . Briefly, the cDNA targets were prepared from 35 µg of total RNA by oligo dT primed polymerization using Superscript II reverse transcriptase (Life Technologies, Gaithersburg, MD). Reverse transcription and labeling with fluorescent dyes, Cy3 and Cy5 (Amersham Pharmacia Biotech, Piscataway, NJ) were as previously described (Duggan et al., 1999; Hamadeh et al., 2002a) . Analyses were 76 IRWIN ET AL.
TOXICOLOGIC PATHOLOGY performed twice per sample using a dye-reversal procedure in which control mRNA was labeled with Cy3 and mRNA from treated rats with Cy5; in the second analysis control mRNA was labeled with Cy5 and mRNA from treated rats with Cy3 to minimize error due to fluor-associated bias. Fluorescent intensities were measured with an Agilent DNA Microarray scanner (Palo Alto, CA). To quantify and normalize the signal intensities from the cDNA spots on the image files, IPLabs image-processing software (Scanalytics, Inc., Fairfax, VA) with Array Suite 2.0 extension (National Human Genome Research Institute, NHGRI, Bethesda, MD) based on an algorithm developed by Yedong Chen (Chen et al., 1997) was utilized. These programs identify, based on a user-defined confidence level, genes that demonstrate statistically significant expression changes, after extraction of pixel intensity values from each scanned channel, computation of ratio values from the signals, and normalization of ratios to the average ratios of all clones on the chip. Genes and ESTs identified within a 95% confidence level as being up or down regulated were stored in MAPS, a validation of replicate gene database utilized for management and statistical expression data (Bushel et al., 2001) . Binomial distribution was used to detect occurrence of differentially expressed genes among 6 independent hybridization trials, which include 2 analyses with fluor reversal for each RNA sample. To assure reproducibility of the observed gene expression changes between different individuals, we considered only differentially expressed genes at the 95% confidence level. We calculated the coefficient of variation (CV) for each gene across replicate hybridizations (CV = standard deviation/average absolute values of the calibrated ratio), using log2 ratio intensity values of the genes detected as differentially expressed at a given confidence level. Genes with a CV value greater than 0.8 were eliminated from further statistical analysis. Cluster and TreeView (Eisen et al., 1998) were used to visualize gene changes occurring at each dose and time point (Hamadeh et al., 2002b) .
Gene Expression Patterns Associated with Acute Acetaminophen Exposures:
The objective was to examine the patterns of gene expression in the liver after doses of acetaminophen ranging from nontoxic to overtly toxic, with the goal of identifying signatures in the gene expression profile associated with the toxic phenotype produced by each dose. In this context toxic phenotype refers to the histopathological changes observed in the liver. Therefore we are attempting to correlate specific histopathological observations with signature patterns of gene expression. Figure 2 shows histological sections of the liver taken at 24 or 48 hours after oral (gavage) administration of 1,500 or 2,000 mg/kg acetaminophen to male F344 rats. The sections reveal a progressive development of hepatocellular injury in centrilobular regions adjacent to the terminal hepatic venule (central vein). At both doses very little change could be seen on routine H&E sections at 6 hours. At 24 hours following the single acute oral administration of 1,500 mg/kg, there was loss of cytoplasmic vacuoles in hepatocytes adjacent to the terminal hepatic venule (Figure 2A ). There was also a mild infiltrate of mononuclear cells and neutrophils and occasional hepatocytes with deeply eosinophilic cytoplasm and pyknotic nuclei. The lesion was similar but more severe and affected more centrilobular areas in rats dosed with 2,000 mg/kg at 24 hours ( Figure 2C) . At 48 hours, there was centrilobular hemorrhage and necrosis at 2,000 mg/kg ( Figure 2D ) but this was less severe at 1,500 mg/kg where the lesions appeared to be resolving ( Figure 2B ).
There were 2 unexpected histopathological findings in the rats receiving a single acute dose of acetaminophen. First there was considerable variation in the severity of the necrosis between rats. The variation between rats for hepatic necrosis was seen again when the study was repeated with 6 animals per dose. The variability between animals following acetaminophen exposure has been seen by others (Wells and To, 1986) and in some studies animals were fasted 12 to 16 hours prior to dosing to reduce variability (Walker et al., 1980) . Second, the degree of severity was not uniform across a sagittal section taken from the midpoint of the left lateral hepatic lobe. This was unexpected since others have suggested that acetaminophen toxicity is uniform across the liver in the rat (Mitchell et al., 1973a) . In order to investigate the distribution of the hepatic necrosis, six rats were dosed with 2000 mg/kg acetaminophen and 9 sections were taken from the 4 liver lobes at 24 and 48 hours. It is clear that the right anterior lobe is much more severely affected than the left lateral lobe (Figure 3 ). We confirmed that following a single acute oral exposure there was marked variation in the degree of necrosis within and between liver lobes. This may be related to the three dimensional parenchymal units that have been described in the rat liver (Teutsch et al., 1999) . The variability between animals and between regions of organs are critical issues for toxicologists and pathologists in reducing variability and improving interpretation of microarray experiments.
The results of hierarchical clustering in 2 dimensions of the corresponding gene expression data from livers of acetaminophen exposed male rats at 6, 24, and 48 hours after administration 2,000 mg/kg bw is shown in Figure 4 . Examination of the cluster in Figure 4 reveals several interesting features. The patterns of gene expression at the 3 time points were distinctly different as was the development and progression of hepatocellular injury observed in the histological sections. The animals evaluated at 24 and 48 hours clustered in a different node than the 6-hour animals as indicated in the dendrogram on the right in the figure. The greatest number of differentially expressed genes were observed at 24 and 48 hours after dosing; however the pattern of gene expression at 24 hours was quite different than that at 48 hours. There is a large group of genes in the middle of the cluster that are up regulated (red) at 24 hours, but not at 6 hours or 48 hours. This cluster gives a nice overview of where one may want to start looking for genes of interest. For example, the genes to the right are generally more upregulated with time while the genes to the left are more down regulated at 24 and especially at 48 hours. The cluster also shows individual animal differences. For example at, 48 hours, rats 3117 and 3118 are more similar to each other than they are to rat 3119. At this stage, one may want to check clinical chemistry and histopathology results for rat 3119. Figure 5 shows the 2 dimensional hierarchical clustering of gene expression data from the livers of male F344 rats 6, 24, and 48 hours after administration of a single oral dose of 1,500 mg/kg acetaminophen. All animals from a single time group are clustered together with the 6-hour animals 2A-1,500 mg/kg at 24 hours, 2B-1,500 mg/kg at 48 hours, 2C-2,000 mg/kg at 24 hours, 2D-2,000 mg/kg at 48 hours (H&E stain). 3.-Cross-section taken from the middle of the left hepatic lobe (3A) in the same rat as the right anterior lobe (3B). The rat received 2,000 mg/kg of acetaminophen 24 hours previously. The interanimal variability is also demonstrated by the difference between this rat and the previous Figure ( clustering in a different node form the 24-and 48-hour animals. However the pattern of up and down regulated genes is quite different from rats exposed to 2,000 mg/kg. One of the most obvious differences is the presence of a group of down regulated genes in the 6-hour animals not present in the 2,000 mg/kg animals at 6 hours. Again depending on ones hypothesis or interest, this may be worth further exploration.
The distinct patterns of gene expression in the liver following exposure to acetaminophen clearly differ with dose, and within each dose differ with time after exposure. The differing patterns of gene expression at each dose and time likely reflect the differing phases of hepatocellular injury revealed in the histological sections at the corresponding time points. Moreover, the molecular events occurring in the liver as reflected by the differing pattern of gene expression, appear to have some correlation with the processes observed in the histological sections at the corresponding doses and times. Thus the gene expression pattern at each dose and time is anchored to the corresponding histological phenotype.
The next challenge is to examine individual genes or groups of genes in an attempt to extract information about the mechanism of toxicity and the processes occurring in the liver in response to the toxic insult. Unfortunately, at the present time there is no uniform or systematic way of identifying potentially important genes except by direct examination. A somewhat direct approach is to examine single nodes in the clustergram and inspect the individual genes that have clustered together. This may provide information about the effect of treatment on various metabolic or signaling pathways. For instance, examination of several nodes in the 2,000 mg/kg clustergram revealed down regulation of genes that code for 2 enzymes of lipid biosynthesis. To further examine whether lipid biosynthesis is influenced by treatment, a set of differentially expressed genes that code for enzymes involved in lipid biosynthesis were clustered with the 2,000 mg/kg and 1,500 mg/kg expression data. As can be seen in Figure 6 , this set of genes clustered the 2,000 mg/kg animals into the correct time groups, suggesting that lipid biosynthesis differed at each time. This same set of genes was not as discriminating when clustered with the 1,500 mg/kg gene expression data (Figure 7) . Although results such as those shown in Figure 6 may be an indication of a treatment related response, additional work would be needed to verify this result.
There are several commercially available software products that provide varying degrees of capability with regard to categorizing genes and assigning them into metabolic or signal transduction pathways. Undoubtedly these will be improved and refined over time. However these are tools, and can only provide certain types of information. The difficulty with gene expression data is that it is global in scope, reflecting the state of much of the genome. In the final analysis the investigator must still fit all the pathways etc. together into a biologically meaningful result. In our experience this generally involves working at the level of the individual, differentially expressed genes. Although it is beyond the scope of this article to delve into a discussion of the hundreds of genes differentially expressed after exposure to toxic doses of acetaminophen, there are several factors somewhat specific to the liver that need to be considered when analyzing gene expression data. In the next section we will enumerate several that we believe are of particular importance.
LIVER SPECIFIC CONSIDERATIONS
The liver has a unique architecture intimately associated with its functioning as the major metabolic organ of the body. As a result there are a number of factors that must be considered when designing hepatotoxicity studies and interpreting liver gene expression data.
Zonation of Hepatic Gene Expression:
A potential factor complicating the interpretation of differential gene expression data in liver is the zone specific pattern of gene expression that occurs across the liver acinus. In the mature liver a wide variety of genes coding for enzymes that function in normal metabolic pathways exhibit a gradient of expression, either increasing or decreasing, from periportal to periveneous regions across the hepatic plate. For example key enzymes participating in gluconeogenesis, cholesterol synthesis, and the urea cycle are expressed predominantly in the periportal region. By contrast, enzymes involved in glycolysis and glycogen synthesis are expressed predominantly in the perivenous region. A number of factors are thought to contribute to maintaining zonation including gradients in oxygen tension (Jungermann and Kietzmann, 1997) , specific cell-cell or cell matrix interactions, cell lineage specific imprinting (Oinonen and Lindros, 1998) , and microenvironmental factors (Gupta et al., 1999) .
Since starting this study we have become more familiar with the three dimensional parenchymal units in the rat liver (Teutsch et al., 1999) . There is a reciprocal gradient of glucose and glucose-6-phosphatase from where the portal vessels enter the liver to the distant surface of the lobe (Teutsch, 1985) . The potential regional differences for gene expression are obvious for the kidney and one should take care in selecting the same region for gene expression. It may be that greater specificity in selection of the sample for gene expression of the liver will be necessary to reduce animal-to-animal variation.
A particularly important group of genes involved in the metabolism of a number of hepatotoxicants are those coding for members of the cytochrome P450 family of mixed function oxidases. Several of these genes, including the gene for CYP2E1, one of the CYP isoforms involved in the conversion of acetaminophen into NAPQI, exhibit a very distinct perivenous expression pattern (Mitchell et al., 1973a) . In fact the perivenous expression of P450s has been invoked to explain the centrilobular toxicity of acetaminophen. However when studying zone specific hepatotoxicants at doses that cause cell death, cells located in the target zone (perivenous region of the liver lobule for acetaminophen) will be selectively removed, also removing their transcripts from the overall population. This raises the possibility that when compared to controls, these transcripts will appear to be down regulated, not because of reduced gene expression, but because the cells that express these transcripts are depleted in livers from treated animals. In addition, RNA from periportal hepatocytes may be over represented in the transcript population and appear to be up regulated. Therefore proper interpretation of gene expression data for zone specific hepatotoxicants requires some independent assessment of zone specific necrosis and cell death such as provided by high quality histopathologic data. Additional information provided by techniques such as immunohistochemical staining or other types of special staining should also be considered where possible.
The zonation of gene expression in the liver must be considered when designing toxicogenomic studies in which animals will be exposed to a hepatotoxicant or suspected hepatotoxicant. Drugs or chemicals must be administered by the appropriate route of exposure. This is especially important if this data may be used in human hazard identification or risk assessment. For a compound like acetaminophen that is taken orally by humans, an oral route of exposure should be used in the animal study. Acetaminophen is absorbed through the gastrointestinal tract, enters the liver via the hepatic portal circulation, flows through the liver acinus and exposes the cells in the liver in a specific order from periportal to perivenous. This exposure scenario will have a direct influence on the pattern of gene expression observed in response to different hepatotoxicants.
Numerous studies of acetaminophen have employed intraperitoneal injection as a route of administration. However intraperitoneal injection essentially bathes the liver with a solution of the compound being investigated resulting in nonuniform exposure of liver lobes, different absorption kinetics, and cells on the organ periphery being exposed to the highest concentration of compound. This could lead to gene expression patterns much different than that observed after oral administration and could be misleading for risk assessment purposes.
Nutritional Status: The liver is the major metabolic organ in the body and as such is extremely responsive to the nutritional status of the animal. In animals that have been recently fed, blood glucose, amino acid, fatty acid, and insulin levels will be increased resulting in the induction of enzymes involved in metabolic pathways related to lipogenesis, glycogen synthesis, and ammonia elimination, needed to process the abundance of substrate. By contrast other metabolic pathways such as those involved in gluconeogenesis and fatty acid degradation will be repressed. In light of the above discussion on the zonation of metabolic function in the liver it is not surprising that fed and fasted animals respond differently to hepatotoxicants such as acetaminophen . Thus in any experiment in which gene expression will be evaluated in liver (actually all tissues) the treated and control animals must be very closely matched with regard to nutritional status. Moreover, in studies lasting more than 2 or 3 days the body weights, and food and water consumption of individual animals must be monitored carefully. Reduced body weight associated with reduced intake of food or water as a result of treatment may profoundly influence the pattern of gene expression observed in the liver and thus be a confounding factor that must be taken into account in interpretation.
Mixed Cell Population in the Liver: It is easy to think of the liver as a collection of hepatocytes, but only 60% of the nuclei in the rat liver are hepatocytes (Yokoyama et al., 1953) . When the liver is homogenized for gene expression, all cells within the sample may contribute to the analysis. Thus the toxicogenomic team needs to be aware of at least four other cell types within the liver that may contribute significantly to differential gene expression. Attempting to distinguish the contribution of different cell types to the gene expression profile in the liver is a major challenge facing toxicogenomics.
The second most common cell within the liver is the endothelial cell accounting for 20% of the nuclei but only 3.3% of the protein content of the liver (Kuiper et al., 1994) . Damage to endothelial cells appears to be important for acetaminophen-induced liver failure (Williams et al., 2003) and increased heme oxygenase 1 expression is found in sinusoidal cells following acetaminophen exposure in rats (Bauer et al., 2000) . Following carbon tetrachloride exposure expression of the intercellular adhesion molecule-1 is increased in hepatic endothelial cells by 3 hours (Neubauer et al., 1998) . The difference in susceptibility of inbred strains of mice to cadmium-induced hepatotoxicity is due to genetic variation in the endothelial cells (Liu et al., 1992) . Thus examination of hepatic morphology and gene expression following injury needs to include the endothelial cell.
The third most common cell within the liver is the Kupffer cell accounting for 15% of the hepatic nuclei and 2.5% of the hepatic protein (Kuiper et al., 1994) . Nearly half of the Kupffer cells are located in the periportal region and this may be important with toxicants that cause zonal hepatic damage. Kupffer cells have been reported to be protective (Ju et al., 2002) or to enhance (Michael et al., 1999) acetaminophen hepatotoxicity. Kupffer cell activation is protective for carbon tetrachloride induced hepatotoxicity in rats (Pereira et al., 1997) . It is clear that acetaminophen can induce gene expression changes in Kupffer cells (Blazka et al., 1995; Ruepp et al., 2002) . Most agents that cause hepatotoxicity would be expected to cause Kupffer cell activation that may show up in the differential gene expression. A complication to keep in mind is that mononuclear cell infiltrates of the liver would be difficult to distinguish from Kupffer cell activation when reviewing gene expression data.
The fourth most common cell of the liver is the fat storing cell (Ito cell, Hepatic Stellate Cell, HSC) estimated to be 5-8% of all liver cells (Geerts et al., 1994) . This cell is much more important that the numbers may indicate. Currently hepatic cirrhosis is reported to be due to activation of hepatic stellate cells (Bataller and Brenner, 2001; Cassiman et al., 2002) . The hepatic stellate cell plays an important role in retinoid storage (Vogel et al., 2000) and in portal hypertension (Reynaert et al., 2002) . Hepatic stellate cells transform into myoblasts after liver injury (Kinnman et al., 2001) . This may explain the increased expression of several myosins after acetaminophen exposure in the rat liver. We predict that this fascinating cell will provide increased expression of many unusual genes in the liver. The hepatic stellate cell may be of neural crest origin. It does express many "neural" genes such as neurophysin, synaptogenin, and glial fibrillary acidic protein (GFAP). A good review on this fascinating cell is provided by Geerts (Geerts, 2001) .
The fifth most common cell of the liver is the biliary epithelium accounting for approximately 3 to 5% of the liver cell population (Alpini et al., 1994) . As many hepatotoxins target biliary epithelium this cell population is important to toxicologists and pathologists. Thus it will also become important to toxicogenomic teams. In injury and biliary cirrhosis, biliary cells may express the cluster of genes that comprises the major histocompatibility complex (Alpini et al., 1994) . The biliary epithelium is active in the transport of ions, carbohydrates, and proteins. We anticipate that toxicogenomic studies of chemicals that injure the biliary epithelium will provide useful insights into the role of this cell in hepatic injury.
SUMMARY
Transcriptional profiling with microarrays is a powerful tool with the capability of providing information on tissue and cell specific gene expression. In this chapter we have attempted to provide a discussion of the use of microarrays for the non-specialist and provide some general guidelines about the analysis of microarray data using the liver as an example. It is important to remember that it is only a tool (Maronpot, 2002) and will provide meaningful results only when 82 IRWIN ET AL. TOXICOLOGIC PATHOLOGY properly applied. As is often the case with new experimental tools, the initial utilization is driven more by the technology itself than its application to problem solving, primarily because specialists first used it. However toxicogenomics, the marriage of toxicology and genomics, is interdisciplinary in nature, and based on our experience the design, conduct, and interpretation of toxicogenomic studies requires input from the disciplines of toxicology, pathology, molecular biology, bioinformatics, and possibly others, depending on the type of question being addressed.
